NBN and cancer: Some NBS1 mutations and polymorphisms have been reported to be associated with risk of several cancers, including cancers of the breast, lung, bladder, ovaries, non-Hodgkin lymphoma, malignant melanoma and basal cell carcinoma of the skin [12-18].